Stock Analysts’ Updated EPS Estimates for November 21st (ALLT, BSX, CCS, CIVB, FEAM, GEHC, HAE, HIVE, HOLX, HUMA)

Stock Analysts’ updated eps estimates for Friday, November 21st: Allot (NASDAQ:ALLT) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $12.50 price target on the stock. Boston Scientific (NYSE:BSX) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $132.00 [...]

Read Full Article →